SIO is pleased to provide itsRe updated clinical practice guidelines for breast cancer. In June 2018, ASCO announced endorsement of the guidelines. The guidelines were published in 2017. Researchers analyzed which integrative treatments are most effective and safe for patients with breast cancer. The guidelines are a resource for clinicians and patients to inform evidence-based decisions on the use of integrative therapies during breast cancer treatment. Researchers at US and Canadian institutions evaluated the efficacy and safety of more than 80 therapies.
The Journal of the National Cancer Institute Monograph has published a special issue co-sponsored by SIO, "Advancing the Global Impact of Integrative Oncology"; including a comprehensive definition for integrative oncology. The articles in the special Monograph were all peer-reviewed.
Voting is Now Open for SIO's Board of Trustees Election
Voting is now open for the Society for Integrative Oncology Board of Trustees Election. We are using an online election system to tabulate our votes. All SIO members in good standing have been sent an email invitation to vote. Click here for more details and to see list of nominees. If you are a current SIO member and you have NOT received your invitation and instructions for voting, please contact staff at: email@example.com.
JACM Announces Call for Submissions (Read more)
Early Bird Registration for the 16th International Conference, October 19-21, 2019 in New York, NY, has been extended until August 16 at 11:59 pm (ET). Don't wait to register! The conference theme is: Advancing the Science and Art of Integrative Oncology. Register here. Hotel Room Blocks are still available. The cutoff date for securing the conference group rate is September 17. Click here to reserve your room.
The new deadline to submit patient advocate and clinican scholarship applications for SIO2091's pre-conference workshop, "Sleeping Well After Cancer: Translating Patient-Centered Research into Practice," is August 23, 2019 at 11:59 pm ET. Read more here and apply.
SIO 2019 Conference Educational Sponsor
"The Financial Toxicity of Cancer Care: What Can We Do About It?" by Yousuf Zafar, MD, MHS
presented on November 20, 2013
This webinar highlights the economic and financial impacts of cancer on patients. Dr. Zafar is a gastrointestinal medical oncologist and health services researcher at the Duke Cancer Institute. His research explores ways to improve care delivery for patients with cancer. He has advanced training in health services research and has participated in studies focusing on access to care, cost of care, and comparative effectiveness of care delivery between health systems. His primary area of interest is in the cost of cancer care. He has conducted institutional and national studies on how treatment-related costs impact cancer patients' experience. His current work focuses on how the cost of care can drive medical decision-making and impact the physician-patient relationship.